T1	Participants 13 40	hepatitis B virus infection
T2	Participants 223 242	chronic hepatitis B
T3	Participants 247 312	patients with HBe antigen-positive disease acquired in adult life
T4	Participants 353 376	those infected at birth
T5	Participants 514 589	114 patients given alpha-interferon for chronic hepatitis B virus infection
T6	Participants 594 687	those patients who had received a minimum of 90 million units per m2 total dose over 12 weeks
T7	Participants 1678 1739	patients with chronic infection of less than 2 years duration
